These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21401495)

  • 1. Uridine function in the central nervous system.
    Dobolyi A; Juhász G; Kovács Z; Kardos J
    Curr Top Med Chem; 2011; 11(8):1058-67. PubMed ID: 21401495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2 receptors activated by uracil nucleotides--an update.
    Brunschweiger A; Müller CE
    Curr Med Chem; 2006; 13(3):289-312. PubMed ID: 16475938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tools and drugs for uracil nucleotide-activated P2Y receptors.
    Rafehi M; Müller CE
    Pharmacol Ther; 2018 Oct; 190():24-80. PubMed ID: 29660366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-OMe-uridine-5'-O-(α-boranodiphosphate), a novel nucleotide derivative highly active at the human P2Y(6) receptor protects against death-receptor mediated glial apoptosis.
    Haas M; Ginsburg-Shmuel T; Fischer B; Reiser G
    Neurosci Lett; 2014 Aug; 578():80-4. PubMed ID: 24970757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.
    El-Tayeb A; Qi A; Müller CE
    J Med Chem; 2006 Nov; 49(24):7076-87. PubMed ID: 17125260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the expression of multiple uracil nucleotide-stimulated P2 receptors coupled to smooth muscle contraction in porcine isolated arteries.
    Rayment SJ; Latif ML; Ralevic V; Alexander SP
    Br J Pharmacol; 2007 Mar; 150(5):604-12. PubMed ID: 17262017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and structure of P2Y receptors.
    von Kügelgen I; Hoffmann K
    Neuropharmacology; 2016 May; 104():50-61. PubMed ID: 26519900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta.
    Guns PJ; Korda A; Crauwels HM; Van Assche T; Robaye B; Boeynaems JM; Bult H
    Br J Pharmacol; 2005 Sep; 146(2):288-95. PubMed ID: 15997227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor.
    Nicholas RA; Watt WC; Lazarowski ER; Li Q; Harden K
    Mol Pharmacol; 1996 Aug; 50(2):224-9. PubMed ID: 8700127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2X and P2Y receptors—role in the pathophysiology of the nervous system.
    Puchałowicz K; Tarnowski M; Baranowska-Bosiacka I; Chlubek D; Dziedziejko V
    Int J Mol Sci; 2014 Dec; 15(12):23672-704. PubMed ID: 25530618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uridine receptor: discovery and its involvement in sleep mechanism.
    Kimura T; Ho IK; Yamamoto I
    Sleep; 2001 May; 24(3):251-60. PubMed ID: 11322706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.
    Barrett MO; Sesma JI; Ball CB; Jayasekara PS; Jacobson KA; Lazarowski ER; Harden TK
    Mol Pharmacol; 2013 Jul; 84(1):41-9. PubMed ID: 23592514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.
    Ko H; Carter RL; Cosyn L; Petrelli R; de Castro S; Besada P; Zhou Y; Cappellacci L; Franchetti P; Grifantini M; Van Calenbergh S; Harden TK; Jacobson KA
    Bioorg Med Chem; 2008 Jun; 16(12):6319-32. PubMed ID: 18514530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a carbohydrate recognition motif of purinergic receptors.
    Zhao L; Wei F; He X; Dai A; Yang D; Jiang H; Wen L; Cheng X
    Elife; 2023 Nov; 12():. PubMed ID: 37955640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of distinct receptors in the actions of extracellular uridine nucleotides.
    Boeynaems JM; Communi D; Pirotton S; Motte S; Parmentier M
    Ciba Found Symp; 1996; 198():266-74; discussion 274-7. PubMed ID: 8879830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of antimetabolite action by uridylate trapping.
    Keppler D; Holstege A; Weckbecker G; Fauler J; Gasser T
    Adv Enzyme Regul; 1985; 24():417-27. PubMed ID: 3835824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uracil nucleotides: from metabolic intermediates to neuroprotection and neuroinflammation.
    Lecca D; Ceruti S
    Biochem Pharmacol; 2008 May; 75(10):1869-81. PubMed ID: 18261711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the existence of pyrimidinergic transmission in rat brain.
    Cansev M; Orhan F; Yaylagul EO; Isik E; Turkyilmaz M; Aydin S; Gumus A; Sevinc C; Coskun N; Ulus IH; Wurtman RJ
    Neuropharmacology; 2015 Apr; 91():77-86. PubMed ID: 25541414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.
    Pendergast W; Yerxa BR; Douglass JG; Shaver SR; Dougherty RW; Redick CC; Sims IF; Rideout JL
    Bioorg Med Chem Lett; 2001 Jan; 11(2):157-60. PubMed ID: 11206448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and function of the metabotropic purinergic P2Y receptor family in experimental seizure models and patients with drug-refractory epilepsy.
    Alves M; Gomez-Villafuertes R; Delanty N; Farrell MA; O'Brien DF; Miras-Portugal MT; Hernandez MD; Henshall DC; Engel T
    Epilepsia; 2017 Sep; 58(9):1603-1614. PubMed ID: 28733972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.